AmerisourceBergen Corp. (NYSE:ABC) insider Dale Danilewitz sold 2,012 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $74.99, for a total transaction of $150,879.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Dale Danilewitz also recently made the following trade(s):

  • On Thursday, October 5th, Dale Danilewitz sold 2,012 shares of AmerisourceBergen Corp. stock. The shares were sold at an average price of $85.00, for a total transaction of $171,020.00.

AmerisourceBergen Corp. (ABC) traded down $1.82 during midday trading on Friday, reaching $74.80. 2,722,070 shares of the company were exchanged, compared to its average volume of 2,235,893. AmerisourceBergen Corp. has a 1-year low of $68.71 and a 1-year high of $97.85. The company has a debt-to-equity ratio of 1.62, a current ratio of 0.91 and a quick ratio of 0.47. The stock has a market capitalization of $16.39 billion, a P/E ratio of 12.43, a PEG ratio of 1.31 and a beta of 0.95.

AmerisourceBergen Corp. (NYSE:ABC) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.32 by $0.01. AmerisourceBergen Corp. had a net margin of 0.27% and a return on equity of 55.99%. The business had revenue of $39.12 billion during the quarter, compared to the consensus estimate of $40.10 billion. During the same quarter last year, the company posted $1.30 earnings per share. The firm’s quarterly revenue was up 4.2% compared to the same quarter last year. research analysts predict that AmerisourceBergen Corp. will post 6.02 earnings per share for the current fiscal year.

WARNING: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/amerisourcebergen-corp-abc-insider-dale-danilewitz-sells-2012-shares/1678816.html.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Parallel Advisors LLC increased its stake in shares of AmerisourceBergen Corp. by 3.2% in the second quarter. Parallel Advisors LLC now owns 1,109 shares of the company’s stock worth $104,000 after purchasing an additional 34 shares in the last quarter. Sun Life Financial INC increased its stake in shares of AmerisourceBergen Corp. by 15,000.0% in the second quarter. Sun Life Financial INC now owns 1,208 shares of the company’s stock worth $114,000 after purchasing an additional 1,200 shares in the last quarter. D.A. Davidson & CO. boosted its position in shares of AmerisourceBergen Corp. by 29.0% in the second quarter. D.A. Davidson & CO. now owns 1,668 shares of the company’s stock valued at $157,000 after acquiring an additional 375 shares during the period. Trust Co. of Vermont boosted its position in shares of AmerisourceBergen Corp. by 82.8% in the second quarter. Trust Co. of Vermont now owns 1,755 shares of the company’s stock valued at $165,000 after acquiring an additional 795 shares during the period. Finally, Washington Trust Bank boosted its position in shares of AmerisourceBergen Corp. by 13.4% in the second quarter. Washington Trust Bank now owns 1,920 shares of the company’s stock valued at $181,000 after acquiring an additional 227 shares during the period. Institutional investors and hedge funds own 67.49% of the company’s stock.

ABC has been the topic of a number of analyst reports. Jefferies Group LLC set a $85.00 price objective on shares of AmerisourceBergen Corp. and gave the company a “hold” rating in a research note on Sunday, October 29th. Leerink Swann set a $90.00 price objective on shares of AmerisourceBergen Corp. and gave the company a “buy” rating in a research note on Monday, August 7th. ValuEngine raised shares of AmerisourceBergen Corp. from a “hold” rating to a “buy” rating in a research note on Tuesday. TheStreet lowered shares of AmerisourceBergen Corp. from a “b” rating to a “c+” rating in a research note on Thursday, August 3rd. Finally, Needham & Company LLC set a $93.00 price objective on shares of AmerisourceBergen Corp. and gave the company a “buy” rating in a research note on Tuesday, October 24th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. AmerisourceBergen Corp. has an average rating of “Hold” and a consensus price target of $91.13.

AmerisourceBergen Corp. Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Insider Buying and Selling by Quarter for AmerisourceBergen Corp. (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.